Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 1
1999 1
2000 1
2005 1
2006 1
2012 2
2013 1
2016 2
2019 1
2020 2
2021 2
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Retraction Notice.
Hong Z, Yanfang J, Shumei H, Jie S, Qing G, Xiangwei F, Bing D, Wei W, Xiaodong S, Chunyan W, Siqi Z, Wanyu L, Junyan F, Junqi N. Hong Z, et al. Among authors: xiaodong s. Turk J Gastroenterol. 2021 Nov;32(11):995. doi: 10.5152/tjg.2021.241121. Turk J Gastroenterol. 2021. PMID: 34872901 Free PMC article. No abstract available.
[Terpenoids from Toona sinensis].
Jiang HU, Jia-Xun LI, Qiang LI, Tian-Feng P, Xiao-Dong S, Tao L, Jian C, Nian-Hua J, Wei-Xing Y, Wei W. Jiang HU, et al. Zhongguo Zhong Yao Za Zhi. 2020 Sep;45(18):4411-4415. doi: 10.19540/j.cnki.cjcmm.20200608.202. Zhongguo Zhong Yao Za Zhi. 2020. PMID: 33164370 Chinese.
Young-IFSO Bariatric/Metabolic Surgery Training and Education Survey.
Felsenreich DM, Yang W, Taskin HE, Abdelbaki T, Shahabi S, Zakeri R, Talishinskiy T, Gero D, Neimark A, Chiappetta S; Young IFSO Collaborative Group. Felsenreich DM, et al. Obes Surg. 2023 Sep;33(9):2816-2830. doi: 10.1007/s11695-023-06751-8. Epub 2023 Jul 28. Obes Surg. 2023. PMID: 37505341
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial.
Lanzetta P, Korobelnik JF, Heier JS, Leal S, Holz FG, Clark WL, Eichenbaum D, Iida T, Xiaodong S, Berliner AJ, Schulze A, Schmelter T, Schmidt-Ott U, Zhang X, Vitti R, Chu KW, Reed K, Rao R, Bhore R, Cheng Y, Sun W, Hirshberg B, Yancopoulos GD, Wong TY; PULSAR Investigators. Lanzetta P, et al. Among authors: xiaodong s. Lancet. 2024 Mar 23;403(10432):1141-1152. doi: 10.1016/S0140-6736(24)00063-1. Epub 2024 Mar 7. Lancet. 2024. PMID: 38461841 Clinical Trial.
18 results